Items where authors include "Whitehouse, J.L."

Article

Caley, L.R. orcid.org/0000-0001-8957-1018, Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Smith, L. orcid.org/0000-0002-4280-6323 et al. (11 more authors) (2023) Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis. Journal of Cystic Fibrosis, 22 (6). pp. 1002-1009. ISSN 1569-1993

Hurst, J.R., Verma, N., Lowe, D. et al. (32 more authors) (2017) British Lung Foundation/United Kingdom primary immunodeficiency network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders. Journal of Allergy and Clinical Immunology: In Practice, 5 (4). pp. 938-945. ISSN 2213-2198

Proceedings Paper

Caley, L. orcid.org/0000-0001-8957-1018, de Goffau, M.C., Jones, A.M. et al. (6 more authors) (2023) EPS5.01 Change in gut microbiota following elexacaftor/tezacaftor/ivacaftor (ETI) therapy: preliminary analysis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier .

Caley, L.R. orcid.org/0000-0001-8957-1018, Jarosz-Griffiths, H.H., Smith, L. et al. (11 more authors) (2023) EPS5.06 Changes in body mass index, energy, fat and sodium intake with triple CFTR modulator therapy preliminary analysis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier .